British Journal of Anaesthesia, Vol 82, Issue 2 182-192, Copyright © 1999 by The Board of Management and Trustees of the British Journal of Anaesthesia
U. Schedin, C. G. Frostell and L. E. Gustafsson
Therapy with inhaled nitric oxide in oxygen requires adequate monitoring of
nitric oxide and nitrogen dioxide. The characteristics of chemiluminescence
and electrochemical measurement techniques were determined by analysis of
continuously flowing gas mixtures and comparisons with traceable gas
standards. Gas mixtures were also diluted with mass flow controllers and in
addition created in ventilator breathing systems. Factors influencing the
formation of nitrogen dioxide were defined. Both techniques accurately
measured nitric oxide (10-80 parts per million, ppm) and nitrogen dioxide
(0.5-5 ppm) in normoxic and hyperoxic (90% oxygen) gas in the studied
ranges. Nitrogen dioxide in hyperoxic gas had three origins: (1) from the
premixing point of nitric oxide in nitrogen, (2) as a result of the mixing
process, and (3) from post-mixing and time-dependent continuous formation
of nitrogen dioxide in oxygen. We conclude that adequate monitoring is
possible and that factors affecting nitrogen dioxide generation can be
defined.
CLINICAL INVESTIGATIONS
Formation of nitrogen dioxide from nitric oxide and their measurement in clinically relevant circumstances
Division of Anaesthesia and Intensive Care, Karolinska Institute at Danderyd Hospital, S-182 88 Danderyd, Sweden; Department of Paediatric Anaesthesia and Intensive Care, Karolinska Hospital, Stockholm, Sweden; Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. Weinberger, D. L. Laskin, D. E. Heck, and J. D. Laskin The Toxicology of Inhaled Nitric Oxide Toxicol. Sci., January 1, 2001; 59(1): 5 - 16. [Abstract] [Full Text] [PDF] |
||||
